Patients with locally advanced rectal cancer can safely be spared pelvic radiation

CHICAGO — Most patients with intermediate-risk rectal cancer can undergo curative-intent treatment without the need for pelvic radiation, according to study results presented during a press conference at ASCO Annual Meeting.“Why is this a big deal? It’s a big deal because we have been radiating pelvises to treat this type of rectal cancer for the past 30 years,” Deborah Schrag, MD, MPH, gastrointestinal oncologist, chair of the department of medicine and George J. Bosl chair at Memorial Sloan Kettering Cancer Center, said during a presentation.Standard treatment forRead More